-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Market Analysis of Chemical Machinery Equipment Network ] In recent years, with the normalization of centralized procurement, drug price reduction has become a major trend in the industry, and it has also begun to force the pharmaceutical industry to accelerate its transformation and upgrading
.
It is reported that in the past, China's current pharmaceutical industry, dominated by low-end generic drugs, has begun to change.
At present, many pharmaceutical companies are not only deeply cultivating the high-end generic drug market, but also accelerating research and development and expansion in the field of innovative drugs
.
Chemical Machinery Equipment Network Market Analysis Chemical Machinery Equipment.
It is reported that in the past, China's current pharmaceutical industry, dominated by low-end generic drugs, has begun to change.
At present, many pharmaceutical companies are not only deeply cultivating the high-end generic drug market, but also accelerating research and development and expansion in the field of innovative drugs
.
It is worth noting that with the rapid development of the pharmaceutical industry in recent years, China's pharmaceutical equipment industry has also begun to show a trend of high prosperity
.
According to the data, in addition to the market growth rate of more than 20% in recent years, the market size of the pharmaceutical equipment industry has also grown from over 45 billion yuan in 2018 to nearly 100 billion yuan in 2019
.
The industry expects that, driven by multiple factors such as the continuous introduction of favorable policies, the continuous influx of overseas capital, and the return of talents in large numbers, the demand for pharmaceutical equipment will continue to grow, and the market size in 2021 may sprint to the 200 billion yuan mark
.
Pharmaceutical equipment.
According to the data, in addition to the market growth rate of more than 20% in recent years, the market size of the pharmaceutical equipment industry has also grown from over 45 billion yuan in 2018 to nearly 100 billion yuan in 2019
.
The industry expects that, driven by multiple factors such as the continuous introduction of favorable policies, the continuous influx of overseas capital, and the return of talents in large numbers, the demand for pharmaceutical equipment will continue to grow, and the market size in 2021 may sprint to the 200 billion yuan mark
.
From the above point of view, the domestic pharmaceutical equipment industry has entered a "golden period" with the rapid development of the pharmaceutical industry
.
However, it should be noted that in this context, how to achieve cost control and ensure production capacity and supply stability is actually becoming a major challenge in the development of pharmaceutical equipment companies
.
.
However, it should be noted that in this context, how to achieve cost control and ensure production capacity and supply stability is actually becoming a major challenge in the development of pharmaceutical equipment companies
.
It is understood that in order to meet the production capacity expansion needs of major pharmaceutical companies, domestic pharmaceutical equipment companies represented by large companies have begun to develop and deploy new technologies
.
If there are enterprises, they have provided innovative solutions for the continuous production of solid pharmaceuticals, so that the products can be moved from batch production to more efficient continuous production
.
.
If there are enterprises, they have provided innovative solutions for the continuous production of solid pharmaceuticals, so that the products can be moved from batch production to more efficient continuous production
.
In order to meet the needs of pharmaceutical companies for capacity expansion under the "4+7" volume procurement, some pharmaceutical machine companies have proposed the "4+7" centralized water supply overall solution
.
The production capacity of this scheme is 25T/h of purified water and 16T/h of water for injection, which can meet the water demand of six production lines in three workshops at the same time
.
The proposal of this scheme is conducive to improving the water supply capacity of the winning bidders
.
In addition, some pharmaceutical equipment companies said that the company has created an overall solution for oral liquids for a pharmaceutical company, and its digital workshop has a total of 6 production lines, which have passed GMP certification with zero defects
.
"With the implementation of an intelligent and integrated solution, the cost savings in one year can basically recoup the investment
.
"
.
The production capacity of this scheme is 25T/h of purified water and 16T/h of water for injection, which can meet the water demand of six production lines in three workshops at the same time
.
The proposal of this scheme is conducive to improving the water supply capacity of the winning bidders
.
In addition, some pharmaceutical equipment companies said that the company has created an overall solution for oral liquids for a pharmaceutical company, and its digital workshop has a total of 6 production lines, which have passed GMP certification with zero defects
.
"With the implementation of an intelligent and integrated solution, the cost savings in one year can basically recoup the investment
.
"
In addition to accelerating the development of more energy-efficient and efficient pharmaceutical equipment to help pharmaceutical companies increase production capacity, many companies are also accelerating the production capacity of their corresponding product lines
.
For example, the fourth phase of Chutian Science and Technology Project is an important construction project based on the needs of its development strategy
.
.
For example, the fourth phase of Chutian Science and Technology Project is an important construction project based on the needs of its development strategy
.
It is understood that the project officially started construction on April 28, 2020, covering an area of 142 acres.
The engineering projects include the Chutian Science and Technology Innovation Center Building, the Talent Center Building, the Intelligent After-Sales Workshop, and the Intelligent Traditional Chinese Medicine Workshop and other R&D, manufacturing and management units The total investment of the entire project is 1.
2-1.
6 billion yuan, and the construction is planned to be completed in the first half of 2022
.
Among them, the intelligent after-package workshop has been completed on December 27, 2020, and is accelerating the increase of the production capacity of the corresponding product lines of Chutian Technology
.
When all completed, it is expected to become a global R&D and manufacturing base for medical equipment
.
The engineering projects include the Chutian Science and Technology Innovation Center Building, the Talent Center Building, the Intelligent After-Sales Workshop, and the Intelligent Traditional Chinese Medicine Workshop and other R&D, manufacturing and management units The total investment of the entire project is 1.
2-1.
6 billion yuan, and the construction is planned to be completed in the first half of 2022
.
Among them, the intelligent after-package workshop has been completed on December 27, 2020, and is accelerating the increase of the production capacity of the corresponding product lines of Chutian Technology
.
When all completed, it is expected to become a global R&D and manufacturing base for medical equipment
.
In general, under the background of rising labor costs and the continuous advancement of medical reform, pharmaceutical companies need to seek a production model that is efficient, low-cost, and quality and quantity guaranteed
.
Affected by this, the domestic pharmaceutical equipment industry will also accelerate into the "golden period" of development
.
However, it should be noted that, in view of the current development status of domestic pharmaceutical equipment, relevant pharmaceutical equipment enterprises should also strengthen the communication between R&D investment and enterprises to create new equipment and new technologies that are more in line with the real needs of pharmaceutical enterprises
.
In addition, we must continue to seize new trends and new technologies, continuously optimize and upgrade, and let the equipment continue to help pharmaceutical companies expand production capacity
.
.
Affected by this, the domestic pharmaceutical equipment industry will also accelerate into the "golden period" of development
.
However, it should be noted that, in view of the current development status of domestic pharmaceutical equipment, relevant pharmaceutical equipment enterprises should also strengthen the communication between R&D investment and enterprises to create new equipment and new technologies that are more in line with the real needs of pharmaceutical enterprises
.
In addition, we must continue to seize new trends and new technologies, continuously optimize and upgrade, and let the equipment continue to help pharmaceutical companies expand production capacity
.
Original title: The domestic pharmaceutical machine industry has entered a "golden period" of development, and improving production capacity has become the top priority at present